Disease activity assessment of rheumatoid arthritis in daily practice: Validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI)

Clinical and Experimental Rheumatology

Volumn 27, Issue 4, 2009, Pages 552-559

  Salaffi, Fausto ^a   Cimmino, M A ^b   Leardini, G ^c   Gasparini, S ^a   Grassi, W ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Ospedale Civile di Venezia   (Italy)

Author keywords

CDAI; DAS28; Disease activity; Reliability; Remission; Rheumatoid arthritis; Validity

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL DISEASE ACTIVITY INDEX; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE INCLUDING 28 JOINTS; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELIABILITY; REMISSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; VALIDITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; JOINTS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 70350179340     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. VAN DER HEIJDE DM, VANT HOF MA, VAN RIEL PL et al.: Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 916-920
2. VAN GESTEL AM, PREVOO ML, VAN'T HOF MA et al.: Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996; 39: 34-40.
3. VAN GESTEL AM, HAAGSMA CJ, VAN RIEL PLCM: Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998; 41: 1845-1850
4. BRITISH SOCIETY FOR RHEUMATOLOGY: Guidelines for prescribing TNFa blockers in adults with rheumatoid arthritis. London: British Society for Rheumatology, 2001. (www.rheumatology.org.uk).
5. FRANSEN J, MOENS HB, SPEYER I et al.: Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis 2005; 64: 1294-1298
6. CREEMERS MC, FRANSEN J, DE GROOT-VOS EH et al.: Implementation of the DAS28 as a routine assessment in daily clinical practice. Ann Rheum Dis 2005; 64 (Suppl. 3): 603.
7. AYLOR WJ, HARRISON AA, HIGHTON J et al: Disease Activity Score 28-ESR bears a similar relationship to treatment decisione across different rheumatologists, but misclassification is too frequent to replace physician judgement. Rheumatology 2008; 47: 514-518
8. KIGSLEY GH, KHOSHABA B, SMITH CM et al.: Are clinical trias in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria. Rheumatology 2005; 44: 629-632
9. BURMESTER GR, FERRACCIOLI GF, FLIPO RM et al.: Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label twelve-week study. Arthritis Care Res 2008; 59: 32-41.
10. GRIGOR C, CAPELL H, STIRLING A et al:. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004; 364: 263-269
11. VAN DER KOOIJ SM, Y P M GOEKOOP-RUITERMAN YPM, J K DE VRIES-BOUWSTRA JK et al.: Probability of continued low disease activity in patients with recent onset rheumatoid arthritis treated according to the disease activity score. Ann Rheum Dis 2008; 67; 266-269
12. DEN BROEDER AA, CREEMERS MCW, VAN GESTEL AM et al.: Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-α. Rheumatology 2002; 41: 638-642
13. SRIKANTH A, GADSBY K, ROSKELL S et al.: Is pre-assessment necessary for rheumatoid arthritis anti-TNF therapy? Rheumatology 2006; 45: i48.
14. LEDINGHAM J, DEIGHTON C: On behalf of the British Society for Rheumatology Standards SGAWG.Update on the British Society for Rheumatology guidelines for prescribing TNF{alpha} blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology 2005; 44: 157-63.
15. VALESINI G, MONTECUCCO C, CUTOLO M: Recommendations for the use of biologic (TNF-α blocking) agents in the treatment of rheumatoid arthritis in Italy. Clin Exp Rheumatol 2006; 24: 413-423
16. FUCHS HA, BROOKS R, CALLAHAN LF et al.: A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum 1989; 32: 531-537
17. PREVOO ML, VAN'T HOF MA, KUPER HH et al.: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-48
18. ALETAHA D, NELL VP, STAMM T et al.: Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005; 7: R796-806.
19. SMOLEN JS, BREEDVELD FC, SCHIFF MH et al.: A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 2003; 42: 244-257
20. ALETAHA D, SMOLEN JS: The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005; 23 (Suppl.) 39: S100-8.
21. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31: 315-324
22. RANZA R, MARCHESONI A, CALORI G et al.: The Italian version of the functional disability index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis. Clin Exp Rheumatol 1993; 11: 123-128
23. KIRWAN JR, REEBACK JS: Stanford Health Assessment Questionnaire modified to assess disability in british patients with rheumatoid arthritis. Br J Rheumatol 1986; 25: 206-209
24. FRANSEN J, CREEMERS MC, VAN RIEL PL: Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology 2004; 43: 1252-1255 (Pubitemid 39359299)
25. ALETAHA D, SMOLEN JS: Remission of rheumatoid arthritis: should we care about definitions? Clin Exp Rheumatol 2006; 24 (Suppl. 43): S45-51.
26. SKINNER HA: Factor analysis and studies on alcohol. A methodological review. J Studies Alcohol 1980; 41: 1091-1101 (Pubitemid 11097581)
27. NUNNALLY JC: Psychometric Theory. 2nd edn. New York: McGraw Hill, 1978.
28. VANDER CRUYSSEN B, VAN LOOY S et al.: DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment. Arthritis Res Ther 2005; 7: R1063-R1071.
29. SMOLEN JS, BREEDVELD FC, SCHIFF MH et al.: A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 2003; 42: 244-257
30. BENTLEY MJ, REED GW: Simplified composite disease activity measures in rheumatoid arthritis: should they be used in standard care?. Clin Exp Rheumatol 2008; 26: 358-66.
31. SHAVER TS, ANDERSON JD, WEIDENSAUL DN et al.: The problem of rheumatoid arthritis disease activity and remission in clinical practice. J Rheumatol 2008; 35: 1015-1022
32. RANGANATH VK, YOON J, KHANNA D et al.: Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Ann Rheum Dis 2007; 66: 1633-1640
33. MAKINEN H, KAUTIAINEN H, HANNONEN P, SOKKA T: Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis 2005; 64: 1410-1413
34. MIERAU M, SCHOELS M, GONDA G et al.: Assessing remission in clinical practice. Rheumatology 2007; 46: 975-979
35. MÄKINEN H, KAUTIAINEN H, HANNONEN P et al.: Disease activity score as an instrument to measure disease activity in patients with early rheumatoid arthritis. J Rheumatol 2007; 34: 1987-1991 (Pubitemid 47548199)
36. KHANNA D, OH M, FURST DE et al.: Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid cohort. Arthritis Rheum 2007; 57: 440-447
37. SOUBRIER M, ZERKAK D, DOUGADOS M: Should we revisit the definition of higher disease activity state in rheumatoid arthritis (RA)? Arthritis Rheum 2004; 50 (Suppl.): S387.
38. DUREZ P, VAN DEN BF, CORLUY L et al.: A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study. Rheumatology 2005; 44: 465-468